Core Outcome Assessments in Cancer Clinical Trials

The Core Outcome Assessments in Cancer Clinical Trials workshop is a full-day workshop that aims to bring together international regulators, payers, members of industry and academia, and patients to advance the science of clinical outcome assessments, which is measuring how patients feel and function. This year’s event will focus on patient-related outcomes (PROs) as they relate to clinical trials, and the FDA Oncology Center of Excellence will use the venue to clarify its position on measuring PROs.

This annual event examines topics beyond the standard assessment endpoints of survival and tumor measurements, including improving methods to quantify how patients experience symptoms and the impact on physical functional outcomes and health-related quality of life.